Nexalin Technology Stock Today
Nexalin Technology is selling for under 0.25 as of the 30th of January 2025; that is No Change since the beginning of the trading day. The stock's lowest day price was 0.25. The performance scores are derived for the period starting the 31st of December 2024 and ending today, the 30th of January 2025. Click here to learn more.
Valuation
Check how we calculate scores
Nexalin Stock Highlights
| CEO, President | Mark White |
| Thematic Idea | Medical Equipment (View all Themes) |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
Nexalin Technology (NXLIW) is traded on NASDAQ Exchange in USA. It is located in 1776 Yorktown, Houston, TX, United States, 77056 and employs 6 people. Nexalin Technology is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company classifies itself under Health Care Equipment & Supplies sector and is part of Health Care industry.
Nexalin Technology generates negative cash flow from operations
Check Nexalin Technology Probability Of Bankruptcy
Nexalin Technology Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Nexalin Technology market risk premium is the additional return an investor will receive from holding Nexalin Technology long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.1031 | |||
| Jensen Alpha | 2.59 | |||
| Total Risk Alpha | 0.5023 | |||
| Sortino Ratio | 0.0853 |
Nexalin Stock Against Markets
Nexalin Technology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nexalin Technology stock to make a market-neutral strategy. Peer analysis of Nexalin Technology could also be used in its relative valuation, which is a method of valuing Nexalin Technology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Nexalin Technology Corporate Management
| Marilyn Elson | Chief Officer | Profile | |
| Joel Bradus | Director Marketing | Profile | |
| Carolyn Shelton | Regulatory Quality | Profile | |
| David MD | Chief Director | Profile | |
| Michael Nketiah | Regulatory Quality | Profile |
Additional Tools for Nexalin Stock Analysis
When running Nexalin Technology's price analysis, check to measure Nexalin Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nexalin Technology is operating at the current time. Most of Nexalin Technology's value examination focuses on studying past and present price action to predict the probability of Nexalin Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nexalin Technology's price. Additionally, you may evaluate how the addition of Nexalin Technology to your portfolios can decrease your overall portfolio volatility.